← FDA Drug Approvals (Drugs@FDA)
DANTROLENE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS · Approved 2005-03-01
Drug application
- FDA Application #
ANDA076856- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DANTROLENE SODIUM
- Generic name
- DANTROLENE SODIUM
- Active ingredients
- DANTROLENE SODIUM
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- IMPAX LABS
- Manufacturer
- Amneal Pharmaceuticals of New York LLC
- First approval
- 2005-03-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown